GSK opts for more transparent drug promotion

GlaxoSmithKline says its new policy of using only in-house medics to promote its products is showing dividends.

It’s been six months since GSK placed a global company-wide ban on paying doctors to speak about its products or funding doctors to attend conferences.

Instead, the pharma giant has recruited 150 doctors internationally, including a team of around 10 Australian-based medics drawn from